SCHEMBL7256263

SCHEMBL7256263

CN(C(N)=O)c1ccc(NC2=C(N3CCCC3)C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APAF1 O14727 11/20 0.63
▸ NPC1 O15118 5/20 0.63
▸ RAB9A P51151 5/20 0.63
▸ CDC25A P30304 1/20 0.62
▸ CDC25B P30305 1/20 0.62
▸ MAPT P10636 13/20 0.62
▸ ALDH1A1 P00352 10/20 0.62
▸ SMN1; SMN2 Q16637 8/20 0.62
▸ HTT P42858 6/20 0.62
▸ POLB P06746 5/20 0.62
▸ LMNA P02545 5/20 0.62
▸ MITF O75030 3/20 0.62
▸ KLF5 Q13887 1/20 0.62
▸ L3MBTL1 Q9Y468 7/20 0.54
▸ MEN1 O00255 7/20 0.54
▸ KMT2A Q03164 7/20 0.54
▸ GAA P10253 6/20 0.54
▸ NPSR1 Q6W5P4 4/20 0.54
▸ NSD2 O96028 3/20 0.54
▸ CASP3 P42574 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7245820 0.90 APAF1 (0.62) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL7253110 0.88 APAF1 (0.62) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL7240512 0.86 MAPT (0.65) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL7240441 0.84 MAPT (0.69) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL7241156 0.82 APAF1 (0.61) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL7248456 0.81 CDC25A (0.59) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL2467093 0.80 APAF1 (0.80) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL7247910 0.79 APAF1 (0.76) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL4874221 0.79 APAF1 (0.97) APAF1NPC1RAB9ACDC25ACDC25B
SCHEMBL4872810 0.79 MAPT (0.76) APAF1NPC1RAB9ACDC25ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6630589-B1 Screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element MESSAGE PHARMACEUTICALS 2003-10-07 — — US disclosed
Send feedback